Automera
Empowering the next evolution in degradation platforms.
10 employees · est. 2022 · Singapore, Singapore
Plexium
Pushing the Boundaries of Targeted Protein Degradation to Improve Lives
35 employees · est. 2018 · San Diego, United States
Plexium is the older company (2022 vs 2018); Plexium is the larger of the two.
Side-by-Side Comparison
| Metric | Automera | Plexium |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2018 older |
| Headquarters | ||
| Headquarters | Singapore, Singapore | San Diego, United States |
| Employees | ||
| Employees | 10 | 35 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $16.00M | $165.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 6 |
| Services | ||
| Services | Not tracked yet | Rational design and discovery of protein degraders, Development of targeted protein degradation therapeutics, Clinical trials |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with high unmet medical needs, Healthcare institutions and systems, Pharmaceutical partners |
| Taxonomy | ||
| Taxonomy | Biotech, Drug Development, Therapeutic Approach, Autophagy, Protein Degradation, Oncology, Cancer, Disease Areas, Quantum Chemistry, AI-enabled Insights, Talo Labs Pte Ltd, Early-stage, AUTAC Platform, Founder-led | Targeted Protein Degradation, Next-Generation Therapeutics, Monovalent Direct Degraders, Molecular Glues, Small Molecule Drugs, High Unmet Medical Needs, DELTA Discovery Platform, Ultra-High Throughput Screening, Cancer Therapies, Clinical-Stage Degraders, Druggable Target Expansion, Protein Degraders, PROTAC Alternatives, Therapeutic Innovation |
| Website | ||
| Website | automeratx.com | plexium.com |
About Automera
Automera is an early-stage biotechnology company founded in 2022 in Singapore. The company's mission is to develop a groundbreaking therapeutic approach through autophagy-based targeted protein degradation. Automera sets itself apart by combining its deep understanding of autophagy with advanced dru...
About Plexium
Plexium, founded in 2018, is a pioneering biotechnology company based in the United States. The company is redefining the landscape of targeted protein degradation (TPD) with the ambitious mission of "Pushing the Boundaries of Targeted Protein Degradation to Improve Lives." Plexium's innovation pr...
We will tell you when either one moves
BounceWatch watches Automera and Plexium for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Automera and Plexium — by email.
Frequently Asked Questions
Compare Automera with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Automera on 12 Sep 2024, and Plexium on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.